annual CFO:
$198.07M+$71.03M(+55.91%)Summary
- As of today (June 22, 2025), CORT annual cash flow from operations is $198.07 million, with the most recent change of +$71.03 million (+55.91%) on December 31, 2024.
- During the last 3 years, CORT annual CFO has risen by +$30.18 million (+17.97%).
- CORT annual CFO is now at all-time high.
Performance
CORT Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$5.13M-$54.17M(-91.35%)Summary
- As of today (June 22, 2025), CORT quarterly cash flow from operations is $5.13 million, with the most recent change of -$54.17 million (-91.35%) on March 31, 2025.
- Over the past year, CORT quarterly CFO has dropped by -$18.63 million (-78.41%).
- CORT quarterly CFO is now -93.05% below its all-time high of $73.83 million, reached on September 30, 2024.
Performance
CORT quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$179.44M-$18.63M(-9.40%)Summary
- As of today (June 22, 2025), CORT TTM cash flow from operations is $179.44 million, with the most recent change of -$18.63 million (-9.40%) on March 31, 2025.
- Over the past year, CORT TTM CFO has increased by +$54.60 million (+43.74%).
- CORT TTM CFO is now -9.40% below its all-time high of $198.07 million, reached on December 31, 2024.
Performance
CORT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CORT Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.9% | -78.4% | +43.7% |
| 3 y3 years | +18.0% | -85.5% | +1.0% |
| 5 y5 years | +45.5% | -84.6% | +23.1% |
CORT Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.6% | -93.0% | at low | -9.4% | +61.6% |
| 5 y | 5-year | at high | +64.6% | -93.0% | at low | -9.4% | +61.6% |
| alltime | all time | at high | +634.5% | -93.0% | +144.4% | -9.4% | +562.9% |
CORT Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $5.13M(-91.4%) | $179.44M(-9.4%) |
| Dec 2024 | $198.07M(+55.9%) | $59.30M(-19.7%) | $198.07M(+36.9%) |
| Sep 2024 | - | $73.83M(+79.3%) | $144.65M(+16.9%) |
| Jun 2024 | - | $41.18M(+73.4%) | $123.73M(-0.9%) |
| Mar 2024 | - | $23.76M(+303.5%) | $124.84M(-1.7%) |
| Dec 2023 | $127.04M(+5.6%) | $5.89M(-88.9%) | $127.04M(-17.8%) |
| Sep 2023 | - | $52.91M(+25.1%) | $154.54M(+14.2%) |
| Jun 2023 | - | $42.29M(+62.9%) | $135.28M(+21.8%) |
| Mar 2023 | - | $25.96M(-22.3%) | $111.03M(-7.7%) |
| Dec 2022 | $120.32M(-28.3%) | $33.39M(-0.8%) | $120.32M(-11.8%) |
| Sep 2022 | - | $33.65M(+86.5%) | $136.36M(-9.9%) |
| Jun 2022 | - | $18.04M(-48.8%) | $151.42M(-14.8%) |
| Mar 2022 | - | $35.25M(-28.7%) | $177.72M(+5.9%) |
| Dec 2021 | $167.89M(+10.5%) | $49.43M(+1.5%) | $167.89M(+9.4%) |
| Sep 2021 | - | $48.70M(+9.8%) | $153.54M(+13.5%) |
| Jun 2021 | - | $44.34M(+74.4%) | $135.28M(-6.1%) |
| Mar 2021 | - | $25.42M(-27.5%) | $144.12M(-5.2%) |
| Dec 2020 | $151.97M(+11.6%) | $35.07M(+15.2%) | $151.97M(-8.1%) |
| Sep 2020 | - | $30.44M(-42.8%) | $165.35M(-4.6%) |
| Jun 2020 | - | $53.19M(+59.9%) | $173.34M(+19.0%) |
| Mar 2020 | - | $33.27M(-31.3%) | $145.71M(+7.0%) |
| Dec 2019 | $136.12M(+17.7%) | $48.45M(+26.1%) | $136.12M(+24.7%) |
| Sep 2019 | - | $38.43M(+50.4%) | $109.18M(-5.3%) |
| Jun 2019 | - | $25.55M(+7.9%) | $115.26M(+9.9%) |
| Mar 2019 | - | $23.68M(+10.0%) | $104.92M(-9.3%) |
| Dec 2018 | $115.67M(+89.8%) | $21.52M(-51.6%) | $115.67M(-2.8%) |
| Sep 2018 | - | $44.51M(+192.6%) | $119.03M(+39.3%) |
| Jun 2018 | - | $15.21M(-55.8%) | $85.45M(-0.4%) |
| Mar 2018 | - | $34.43M(+38.4%) | $85.80M(+40.8%) |
| Dec 2017 | $60.94M(+231.3%) | $24.88M(+127.8%) | $60.94M(+50.0%) |
| Sep 2017 | - | $10.93M(-29.8%) | $40.62M(+5.2%) |
| Jun 2017 | - | $15.57M(+62.8%) | $38.63M(+56.7%) |
| Mar 2017 | - | $9.56M(+109.3%) | $24.66M(+34.1%) |
| Dec 2016 | $18.39M(+487.6%) | $4.57M(-48.9%) | $18.39M(+2.3%) |
| Sep 2016 | - | $8.94M(+461.9%) | $17.98M(+81.1%) |
| Jun 2016 | - | $1.59M(-51.8%) | $9.93M(+21.1%) |
| Mar 2016 | - | $3.30M(-20.8%) | $8.20M(+162.1%) |
| Dec 2015 | $3.13M(-111.4%) | $4.16M(+371.5%) | $3.13M(-228.5%) |
| Sep 2015 | - | $883.00K(-735.3%) | -$2.44M(-73.7%) |
| Jun 2015 | - | -$139.00K(-92.2%) | -$9.25M(-48.9%) |
| Mar 2015 | - | -$1.78M(+26.7%) | -$18.09M(-33.9%) |
| Dec 2014 | -$27.38M | -$1.40M(-76.3%) | -$27.38M(-18.6%) |
| Sep 2014 | - | -$5.93M(-34.0%) | -$33.64M(-7.4%) |
| Jun 2014 | - | -$8.98M(-18.8%) | -$36.31M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$11.06M(+44.3%) | -$36.56M(-1.3%) |
| Dec 2013 | -$37.06M(+2.9%) | -$7.67M(-10.9%) | -$37.06M(-2.8%) |
| Sep 2013 | - | -$8.60M(-6.9%) | -$38.13M(-1.6%) |
| Jun 2013 | - | -$9.24M(-20.1%) | -$38.76M(+3.6%) |
| Mar 2013 | - | -$11.55M(+32.2%) | -$37.42M(+3.9%) |
| Dec 2012 | -$36.02M(+31.5%) | -$8.74M(-5.3%) | -$36.02M(+7.3%) |
| Sep 2012 | - | -$9.23M(+16.9%) | -$33.57M(+8.5%) |
| Jun 2012 | - | -$7.89M(-22.3%) | -$30.95M(+2.3%) |
| Mar 2012 | - | -$10.16M(+61.4%) | -$30.26M(+10.4%) |
| Dec 2011 | -$27.40M(+23.0%) | -$6.29M(-4.7%) | -$27.40M(+3.2%) |
| Sep 2011 | - | -$6.60M(-8.4%) | -$26.56M(+0.7%) |
| Jun 2011 | - | -$7.21M(-1.2%) | -$26.38M(+11.4%) |
| Mar 2011 | - | -$7.29M(+33.7%) | -$23.69M(+6.3%) |
| Dec 2010 | -$22.29M(+24.0%) | -$5.46M(-15.1%) | -$22.29M(+5.1%) |
| Sep 2010 | - | -$6.43M(+42.3%) | -$21.21M(+14.6%) |
| Jun 2010 | - | -$4.52M(-23.3%) | -$18.51M(-8.3%) |
| Mar 2010 | - | -$5.89M(+34.4%) | -$20.19M(+12.4%) |
| Dec 2009 | -$17.97M(-2.1%) | -$4.38M(+17.5%) | -$17.97M(-0.6%) |
| Sep 2009 | - | -$3.73M(-39.8%) | -$18.08M(-1.2%) |
| Jun 2009 | - | -$6.20M(+69.1%) | -$18.30M(+4.3%) |
| Mar 2009 | - | -$3.66M(-18.5%) | -$17.56M(-4.4%) |
| Dec 2008 | -$18.36M(+67.5%) | -$4.49M(+13.7%) | -$18.36M(+7.5%) |
| Sep 2008 | - | -$3.95M(-27.5%) | -$17.09M(+17.9%) |
| Jun 2008 | - | -$5.45M(+21.9%) | -$14.50M(+22.7%) |
| Mar 2008 | - | -$4.47M(+38.8%) | -$11.81M(+7.7%) |
| Dec 2007 | -$10.96M(-52.8%) | -$3.22M(+135.9%) | -$10.96M(-17.5%) |
| Sep 2007 | - | -$1.36M(-50.6%) | -$13.29M(-23.6%) |
| Jun 2007 | - | -$2.76M(-23.8%) | -$17.39M(-17.8%) |
| Mar 2007 | - | -$3.62M(-34.7%) | -$21.15M(-9.0%) |
| Dec 2006 | -$23.24M(+34.8%) | -$5.54M(+1.5%) | -$23.24M(+8.3%) |
| Sep 2006 | - | -$5.46M(-16.3%) | -$21.46M(+10.9%) |
| Jun 2006 | - | -$6.52M(+14.2%) | -$19.35M(+12.3%) |
| Mar 2006 | - | -$5.71M(+51.7%) | -$17.23M(-0.0%) |
| Dec 2005 | -$17.23M(+25.6%) | -$3.77M(+12.4%) | -$17.23M(-6.2%) |
| Sep 2005 | - | -$3.35M(-23.9%) | -$18.37M(-0.5%) |
| Jun 2005 | - | -$4.40M(-23.0%) | -$18.46M(+7.3%) |
| Mar 2005 | - | -$5.71M(+16.6%) | -$17.21M(+25.4%) |
| Dec 2004 | -$13.72M(+37.1%) | -$4.90M(+42.6%) | -$13.72M(+32.6%) |
| Sep 2004 | - | -$3.44M(+9.1%) | -$10.34M(+17.3%) |
| Jun 2004 | - | -$3.15M(+41.6%) | -$8.82M(-3.6%) |
| Mar 2004 | - | -$2.23M(+45.6%) | -$9.14M(-8.6%) |
| Dec 2003 | -$10.00M | -$1.53M(-20.1%) | -$10.00M(+18.0%) |
| Sep 2003 | - | -$1.91M(-45.0%) | -$8.47M(+29.1%) |
| Jun 2003 | - | -$3.48M(+12.7%) | -$6.56M(+112.7%) |
| Mar 2003 | - | -$3.09M | -$3.09M |
FAQ
- What is Corcept Therapeutics Incorporated annual cash flow from operations?
- What is the all time high annual CFO for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual CFO year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash flow from operations?
- What is the all time high quarterly CFO for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly CFO year-on-year change?
- What is Corcept Therapeutics Incorporated TTM cash flow from operations?
- What is the all time high TTM CFO for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM CFO year-on-year change?
What is Corcept Therapeutics Incorporated annual cash flow from operations?
The current annual CFO of CORT is $198.07M
What is the all time high annual CFO for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash flow from operations is $198.07M
What is Corcept Therapeutics Incorporated annual CFO year-on-year change?
Over the past year, CORT annual cash flow from operations has changed by +$71.03M (+55.91%)
What is Corcept Therapeutics Incorporated quarterly cash flow from operations?
The current quarterly CFO of CORT is $5.13M
What is the all time high quarterly CFO for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash flow from operations is $73.83M
What is Corcept Therapeutics Incorporated quarterly CFO year-on-year change?
Over the past year, CORT quarterly cash flow from operations has changed by -$18.63M (-78.41%)
What is Corcept Therapeutics Incorporated TTM cash flow from operations?
The current TTM CFO of CORT is $179.44M
What is the all time high TTM CFO for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM cash flow from operations is $198.07M
What is Corcept Therapeutics Incorporated TTM CFO year-on-year change?
Over the past year, CORT TTM cash flow from operations has changed by +$54.60M (+43.74%)